Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/87145 |
Resumo: | Patients with demyelinating diseases (DDs) such as multiple sclerosis have a 20-fold higher risk of developing trigeminal neuralgia (TN). DD-related TN is more frequently refractory to the usual medical and surgical treatment. We report the case of a 57-year-old man presenting to our neurology outpatient clinic with a 12-year history of medical and surgical refractory TN associated with demyelinating lesions on magnetic resonance imaging. After a new failure of pharmacological treatment with oxcarbazepine, pregabalin, baclofen, and duloxetine, motor cortex stimulation (MCS) was performed, and the patient remained mostly pain-free, without any pharmacological treatment during the 3.5 years of follow-up. MCS may be a useful approach for DD-related refractory TN, and further studies can clarify its role in TN management. |
id |
RCAP_c960fdbc8d789a9ca6f980991cc5700b |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/87145 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgiamotor cortex stimulationpainrefractorytrigeminal neuralgiaPatients with demyelinating diseases (DDs) such as multiple sclerosis have a 20-fold higher risk of developing trigeminal neuralgia (TN). DD-related TN is more frequently refractory to the usual medical and surgical treatment. We report the case of a 57-year-old man presenting to our neurology outpatient clinic with a 12-year history of medical and surgical refractory TN associated with demyelinating lesions on magnetic resonance imaging. After a new failure of pharmacological treatment with oxcarbazepine, pregabalin, baclofen, and duloxetine, motor cortex stimulation (MCS) was performed, and the patient remained mostly pain-free, without any pharmacological treatment during the 3.5 years of follow-up. MCS may be a useful approach for DD-related refractory TN, and further studies can clarify its role in TN management.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Centro de Estudos de Doenças Crónicas (CEDOC)RUNMendonça, Marcelo DSeromenho-Santos, AlexandraCaetano, AndréReizinho, Carla2019-11-13T04:40:55Z2019-07-302019-07-30T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/87145eng2515-8163PURE: 14304625https://doi.org/10.1177/2515816319866149info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:38:54Zoai:run.unl.pt:10362/87145Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:36:43.949280Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia |
title |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia |
spellingShingle |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia Mendonça, Marcelo D motor cortex stimulation pain refractory trigeminal neuralgia |
title_short |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia |
title_full |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia |
title_fullStr |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia |
title_full_unstemmed |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia |
title_sort |
Motor cortex stimulation for refractory demyelinating disease-associated trigeminal neuralgia |
author |
Mendonça, Marcelo D |
author_facet |
Mendonça, Marcelo D Seromenho-Santos, Alexandra Caetano, André Reizinho, Carla |
author_role |
author |
author2 |
Seromenho-Santos, Alexandra Caetano, André Reizinho, Carla |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) Centro de Estudos de Doenças Crónicas (CEDOC) RUN |
dc.contributor.author.fl_str_mv |
Mendonça, Marcelo D Seromenho-Santos, Alexandra Caetano, André Reizinho, Carla |
dc.subject.por.fl_str_mv |
motor cortex stimulation pain refractory trigeminal neuralgia |
topic |
motor cortex stimulation pain refractory trigeminal neuralgia |
description |
Patients with demyelinating diseases (DDs) such as multiple sclerosis have a 20-fold higher risk of developing trigeminal neuralgia (TN). DD-related TN is more frequently refractory to the usual medical and surgical treatment. We report the case of a 57-year-old man presenting to our neurology outpatient clinic with a 12-year history of medical and surgical refractory TN associated with demyelinating lesions on magnetic resonance imaging. After a new failure of pharmacological treatment with oxcarbazepine, pregabalin, baclofen, and duloxetine, motor cortex stimulation (MCS) was performed, and the patient remained mostly pain-free, without any pharmacological treatment during the 3.5 years of follow-up. MCS may be a useful approach for DD-related refractory TN, and further studies can clarify its role in TN management. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-11-13T04:40:55Z 2019-07-30 2019-07-30T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/87145 |
url |
http://hdl.handle.net/10362/87145 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2515-8163 PURE: 14304625 https://doi.org/10.1177/2515816319866149 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137985133805568 |